 David Albeck
Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Growth Factors | 9 | 2005 | 78 | 0.680 |
Why?
| | Social Behavior | 3 | 2019 | 288 | 0.610 |
Why?
| | Oxytocin | 2 | 2018 | 51 | 0.560 |
Why?
| | Receptors, Oxytocin | 1 | 2018 | 20 | 0.560 |
Why?
| | Interpersonal Relations | 1 | 2019 | 400 | 0.470 |
Why?
| | Stress, Psychological | 2 | 2019 | 1153 | 0.400 |
Why?
| | Genotype | 1 | 2018 | 1835 | 0.390 |
Why?
| | Arginine Vasopressin | 4 | 1997 | 44 | 0.280 |
Why?
| | Avoidance Learning | 2 | 2006 | 65 | 0.270 |
Why?
| | Spatial Behavior | 2 | 2006 | 24 | 0.240 |
Why?
| | Discrimination Learning | 1 | 2006 | 54 | 0.230 |
Why?
| | Brain | 6 | 2006 | 2941 | 0.230 |
Why?
| | Corticotropin-Releasing Hormone | 2 | 1997 | 72 | 0.230 |
Why?
| | Nerve Growth Factor | 2 | 2005 | 34 | 0.230 |
Why?
| | Conditioning, Operant | 2 | 2007 | 99 | 0.230 |
Why?
| | Escape Reaction | 1 | 2005 | 56 | 0.220 |
Why?
| | Prosencephalon | 3 | 2005 | 53 | 0.210 |
Why?
| | Brain-Derived Neurotrophic Factor | 2 | 2005 | 148 | 0.210 |
Why?
| | Physical Conditioning, Animal | 1 | 2006 | 243 | 0.200 |
Why?
| | Rats | 14 | 2007 | 5614 | 0.190 |
Why?
| | Aging | 3 | 2006 | 1966 | 0.180 |
Why?
| | Neuropeptides | 2 | 1993 | 77 | 0.180 |
Why?
| | Neuroprotective Agents | 3 | 2001 | 143 | 0.170 |
Why?
| | Nerve Tissue Proteins | 3 | 2001 | 592 | 0.160 |
Why?
| | Adult Survivors of Child Adverse Events | 1 | 2019 | 15 | 0.150 |
Why?
| | Neurons | 6 | 2002 | 1642 | 0.150 |
Why?
| | Blood-Brain Barrier | 2 | 1998 | 155 | 0.150 |
Why?
| | Exposure to Violence | 1 | 2019 | 20 | 0.150 |
Why?
| | Domestic Violence | 1 | 2019 | 51 | 0.140 |
Why?
| | Rats, Inbred F344 | 5 | 2006 | 268 | 0.140 |
Why?
| | Corticosterone | 3 | 1999 | 244 | 0.140 |
Why?
| | Arousal | 1 | 2018 | 157 | 0.130 |
Why?
| | Aggression | 1 | 2019 | 179 | 0.130 |
Why?
| | Sexual Behavior, Animal | 1 | 1997 | 57 | 0.120 |
Why?
| | Behavior, Animal | 3 | 2006 | 520 | 0.120 |
Why?
| | Alleles | 1 | 2018 | 881 | 0.110 |
Why?
| | Hippocampus | 9 | 2005 | 967 | 0.110 |
Why?
| | Electroencephalography | 1 | 2018 | 551 | 0.110 |
Why?
| | Adrenalectomy | 1 | 1994 | 71 | 0.110 |
Why?
| | Androstanols | 1 | 1994 | 30 | 0.110 |
Why?
| | Hypothalamus | 1 | 1994 | 153 | 0.100 |
Why?
| | Students | 1 | 2019 | 663 | 0.100 |
Why?
| | Receptors, Glucocorticoid | 1 | 1994 | 138 | 0.100 |
Why?
| | Emotions | 1 | 2018 | 578 | 0.100 |
Why?
| | Fetal Tissue Transplantation | 4 | 2001 | 33 | 0.100 |
Why?
| | Limbic System | 1 | 1993 | 55 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 6 | 2007 | 2540 | 0.090 |
Why?
| | Synaptic Transmission | 2 | 1991 | 290 | 0.090 |
Why?
| | Amygdala | 4 | 1997 | 198 | 0.090 |
Why?
| | Animals | 20 | 2007 | 38109 | 0.080 |
Why?
| | Male | 14 | 2019 | 72406 | 0.080 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2018 | 2147 | 0.080 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1496 | 0.080 |
Why?
| | Maze Learning | 3 | 2006 | 104 | 0.080 |
Why?
| | Gene Expression | 1 | 1994 | 1490 | 0.070 |
Why?
| | Analysis of Variance | 2 | 2006 | 1311 | 0.070 |
Why?
| | Isoquinolines | 1 | 2007 | 44 | 0.070 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2007 | 108 | 0.060 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 6053 | 0.060 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 1997 | 33 | 0.060 |
Why?
| | Cocaine-Related Disorders | 1 | 2007 | 132 | 0.060 |
Why?
| | Corpus Striatum | 2 | 2005 | 179 | 0.060 |
Why?
| | Cocaine | 1 | 2007 | 161 | 0.060 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2007 | 228 | 0.060 |
Why?
| | Spinal Cord | 2 | 1999 | 382 | 0.060 |
Why?
| | Down Syndrome | 2 | 2002 | 534 | 0.060 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 3 | 2001 | 17 | 0.050 |
Why?
| | Brain Tissue Transplantation | 2 | 2001 | 19 | 0.050 |
Why?
| | Association Learning | 1 | 2005 | 71 | 0.050 |
Why?
| | Reaction Time | 1 | 2006 | 438 | 0.050 |
Why?
| | Time Factors | 3 | 2006 | 7183 | 0.050 |
Why?
| | Female | 5 | 2019 | 78376 | 0.050 |
Why?
| | Parasympathetic Nervous System | 1 | 2002 | 26 | 0.050 |
Why?
| | Exercise Test | 1 | 2006 | 634 | 0.050 |
Why?
| | Young Adult | 1 | 2019 | 14126 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2006 | 538 | 0.040 |
Why?
| | Neuronal Plasticity | 1 | 2005 | 309 | 0.040 |
Why?
| | Growth Substances | 1 | 2002 | 140 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2002 | 64 | 0.040 |
Why?
| | Brain Mapping | 1 | 2005 | 537 | 0.040 |
Why?
| | Fear | 1 | 2005 | 366 | 0.040 |
Why?
| | Aspartic Acid | 1 | 2001 | 88 | 0.040 |
Why?
| | Acetylcholine | 1 | 2002 | 206 | 0.040 |
Why?
| | Electric Stimulation | 2 | 1993 | 276 | 0.040 |
Why?
| | Substantia Nigra | 1 | 2001 | 63 | 0.040 |
Why?
| | Dopamine | 2 | 2001 | 289 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2019 | 17101 | 0.040 |
Why?
| | Social Facilitation | 1 | 2000 | 9 | 0.040 |
Why?
| | Humans | 6 | 2019 | 144957 | 0.040 |
Why?
| | Mesencephalon | 1 | 2000 | 65 | 0.040 |
Why?
| | Septum Pellucidum | 1 | 1999 | 5 | 0.040 |
Why?
| | Ocular Physiological Phenomena | 1 | 1999 | 10 | 0.040 |
Why?
| | Estrogens | 1 | 2002 | 380 | 0.040 |
Why?
| | Adolescent | 1 | 2019 | 22453 | 0.040 |
Why?
| | Receptor, Nerve Growth Factor | 1 | 1999 | 3 | 0.040 |
Why?
| | Receptor, trkA | 1 | 1999 | 15 | 0.040 |
Why?
| | Neurites | 1 | 1999 | 50 | 0.040 |
Why?
| | Child | 1 | 2019 | 22657 | 0.040 |
Why?
| | Anterior Chamber | 1 | 1999 | 27 | 0.040 |
Why?
| | Aged | 1 | 2019 | 25947 | 0.040 |
Why?
| | Graft Survival | 1 | 2001 | 526 | 0.040 |
Why?
| | Brain Chemistry | 1 | 1999 | 116 | 0.040 |
Why?
| | Social Environment | 1 | 2000 | 254 | 0.040 |
Why?
| | Cognition | 3 | 2002 | 1269 | 0.030 |
Why?
| | Bone Morphogenetic Proteins | 1 | 1999 | 142 | 0.030 |
Why?
| | RNA, Messenger | 2 | 1997 | 2832 | 0.030 |
Why?
| | Dominance-Subordination | 1 | 1997 | 16 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2007 | 2032 | 0.030 |
Why?
| | Environment | 1 | 1999 | 305 | 0.030 |
Why?
| | Middle Aged | 1 | 2019 | 35928 | 0.030 |
Why?
| | In Situ Hybridization | 1 | 1997 | 319 | 0.030 |
Why?
| | Cell Count | 1 | 1997 | 321 | 0.030 |
Why?
| | Motor Neurons | 1 | 1999 | 234 | 0.030 |
Why?
| | Eye | 1 | 1997 | 109 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 1999 | 479 | 0.030 |
Why?
| | Adult | 1 | 2019 | 40506 | 0.030 |
Why?
| | Alzheimer Disease | 1 | 2002 | 622 | 0.030 |
Why?
| | Supraoptic Nucleus | 1 | 1994 | 4 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2002 | 1718 | 0.030 |
Why?
| | Drug Implants | 1 | 1994 | 83 | 0.030 |
Why?
| | Injections, Intraventricular | 2 | 2007 | 58 | 0.030 |
Why?
| | Vasopressins | 1 | 1993 | 60 | 0.020 |
Why?
| | Cell Line | 1 | 1997 | 2882 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 1995 | 479 | 0.020 |
Why?
| | Stress, Physiological | 1 | 1995 | 453 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 1991 | 321 | 0.020 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2001 | 71 | 0.020 |
Why?
| | Neural Inhibition | 1 | 1991 | 178 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 851 | 0.020 |
Why?
| | Reinforcement Schedule | 1 | 2007 | 25 | 0.020 |
Why?
| | Self Administration | 1 | 2007 | 124 | 0.020 |
Why?
| | Gestational Age | 2 | 2001 | 975 | 0.020 |
Why?
| | Mice, Knockout | 2 | 2006 | 3125 | 0.020 |
Why?
| | Motor Activity | 2 | 2002 | 722 | 0.010 |
Why?
| | Catheterization, Peripheral | 1 | 2007 | 119 | 0.010 |
Why?
| | Data Interpretation, Statistical | 1 | 2007 | 372 | 0.010 |
Why?
| | Fragile X Syndrome | 1 | 2006 | 119 | 0.010 |
Why?
| | Memory Disorders | 1 | 2006 | 194 | 0.010 |
Why?
| | Synapses | 2 | 2002 | 439 | 0.010 |
Why?
| | Choline O-Acetyltransferase | 1 | 2002 | 25 | 0.010 |
Why?
| | Receptors, Cholinergic | 1 | 2002 | 41 | 0.010 |
Why?
| | Transplantation, Heterotopic | 1 | 2001 | 16 | 0.010 |
Why?
| | Sympathetic Nervous System | 1 | 2002 | 178 | 0.010 |
Why?
| | Mice | 3 | 2006 | 18365 | 0.010 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 121 | 0.010 |
Why?
| | Neuropsychological Tests | 1 | 2006 | 1137 | 0.010 |
Why?
| | Caspase Inhibitors | 1 | 2001 | 81 | 0.010 |
Why?
| | Neurotrophin 3 | 1 | 2000 | 10 | 0.010 |
Why?
| | Environment Design | 1 | 2000 | 27 | 0.010 |
Why?
| | Play and Playthings | 1 | 2000 | 35 | 0.010 |
Why?
| | Rhombencephalon | 1 | 2000 | 31 | 0.010 |
Why?
| | Housing, Animal | 1 | 2000 | 46 | 0.010 |
Why?
| | Long-Term Potentiation | 1 | 2002 | 200 | 0.010 |
Why?
| | Social Isolation | 1 | 2000 | 72 | 0.010 |
Why?
| | Grooming | 1 | 1999 | 9 | 0.010 |
Why?
| | Bone Morphogenetic Protein 7 | 1 | 1999 | 12 | 0.010 |
Why?
| | Entorhinal Cortex | 1 | 1999 | 15 | 0.010 |
Why?
| | Estradiol | 1 | 2002 | 533 | 0.010 |
Why?
| | Antigens, Differentiation | 1 | 1999 | 77 | 0.010 |
Why?
| | Visual Cortex | 1 | 1999 | 84 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2001 | 826 | 0.010 |
Why?
| | Cell Survival | 1 | 2000 | 1098 | 0.010 |
Why?
| | Cerebral Cortex | 1 | 2000 | 465 | 0.010 |
Why?
| | Fetus | 1 | 2001 | 803 | 0.010 |
Why?
| | Antibodies | 1 | 1999 | 403 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2006 | 4569 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2006 | 5997 | 0.010 |
Why?
| | Atrophy | 1 | 1995 | 201 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1999 | 781 | 0.010 |
Why?
| | Apoptosis | 1 | 2001 | 2430 | 0.010 |
Why?
| | Age Factors | 1 | 1999 | 3335 | 0.010 |
Why?
| | Evoked Potentials | 1 | 1991 | 128 | 0.000 |
Why?
| | Infant, Newborn | 1 | 1995 | 6434 | 0.000 |
Why?
|
|
Albeck's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|